Sunshine Biopharma (SBFMW) Invested Capital (2016 - 2025)
Historic Invested Capital for Sunshine Biopharma (SBFMW) over the last 14 years, with Q3 2025 value amounting to $24.2 million.
- Sunshine Biopharma's Invested Capital fell 335.45% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 335.45%. This contributed to the annual value of $23.5 million for FY2024, which is 1081.41% up from last year.
- As of Q3 2025, Sunshine Biopharma's Invested Capital stood at $24.2 million, which was down 335.45% from $25.7 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Invested Capital ranged from a high of $41.9 million in Q2 2022 and a low of -$1.2 million during Q3 2021
- Its 5-year average for Invested Capital is $19.6 million, with a median of $22.7 million in 2025.
- As far as peak fluctuations go, Sunshine Biopharma's Invested Capital soared by 1011797.49% in 2022, and later crashed by 4561.36% in 2023.
- Sunshine Biopharma's Invested Capital (Quarter) stood at $211662.0 in 2021, then skyrocketed by 10117.97% to $21.6 million in 2022, then decreased by 1.94% to $21.2 million in 2023, then rose by 10.81% to $23.5 million in 2024, then rose by 2.97% to $24.2 million in 2025.
- Its last three reported values are $24.2 million in Q3 2025, $25.7 million for Q2 2025, and $22.7 million during Q1 2025.